Vyne Therapeutics Inc (VYNE) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Mar 31 2025 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Vyne Therapeutics Inc   (NASDAQ: VYNE)


Vyne Therapeutics Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Vyne Therapeutics Inc's ROI in the second quarter of 2026?
Vyne Therapeutics Inc recorded a cumulative net loss of $-12 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -43.43%.

Within the Healthcare sector 444 other companies had a higher return on investment. While Return on investment, overall ranking has progressed in the Jun 30 2026 quarter, so far to 3767, from total ROI ranking in the first quarter of 2026 at 4509.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter
Y / Y Investment Change TTM -51.7 % -50.8 % -48.02 % -24.36 % 13.74 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 22 25 28 39 44
Return On Investment (TTM) -43.43 % -52.91 % -64.71 % -77.62 % -71.93 %
VYNE's Overall Ranking # 3767 # 4509 # # 4095 # 4098
Seq. Investment Change TTM -16.3 % -16.85 % -18.01 % -15.35 % -14.75 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -12 -18 -26 -39 -42

VYNE Company Profile >> Back to VYNE Roi Comparisons >> See Annual VYNE Return On Investment



Return On Investment VYNE's Ranking
Within: No.
Industry # 178
Sector # 445
Overall # 3767

Return On Investment Statistics
High Average Low
278.29 %
-3.06 %
-150.27 %
(Dec 31 2020)   (Dec 31 2019)







Financial Statements
Vyne Therapeutics Inc's II. Quarter Investments $ 22 Millions VYNE's Balance sheet
Vyne Therapeutics Inc's II. Quarter Income $ -3 Millions Quarterly VYNE's Income Statement
VYNE's Income by Division See VYNE's Income by Division


VYNE Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 28 52 90 41 49
Y / Y Investment Growth -46.69 % -42.22 % 121.18 % -16.2 % -32.72 %
Net Income in Millions -26 -40 -28 -23 73
Y / Y Net Income Growth - - - - -71.31 %
Annual Return On Investment -95.38 % -76.48 % -31.56 % -56.95 % 150.77 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
VYNE's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for VYNE's Competitors
Subscribers only: Roi for Vyne Therapeutics Inc's Suppliers
Subscribers only: Return On Investment for VYNE's Customers

Other Ratios
VYNE's Roa VYNE's Inventory Turnover Ratio VYNE's Growth Rates VYNE's Dividend Statistics
VYNE's Profitability Ratios VYNE's Asset Turnover Ratio VYNE's Dividend Growth
VYNE's Roe VYNE's Valuation Ratios VYNE's Financial Strength Ratios VYNE's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI

Date modified: 2026-09-02T20:18:22+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.